Contract sales & marketing

Probiotic Powerhouses & Pioneers: Top 10 acquisition targets for growth in the APAC region

Content provided by William Reed | 21-Jun-2023 | White Paper

According to a recent report, the APAC region saw the highest growth in online sales of probiotic supplements worldwide in 2022.

Keys To A Successful Rapid Commercial Launch

Content provided by Catalent | 21-Oct-2020 | Insight Guide

Pharma and biotech companies are dedicating resources to new treatments with the hope of helping patients. The quicker they can get products to patients,...

Local lab Data Management

Content provided by Q² Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Content provided by Q² Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Content provided by Frontage Laboratories | 01-Dec-2019 | White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...

How to Avoid Surprises in Small-Molecule Drug Development Programs

Content provided by Frontage Laboratories | 01-Oct-2019 | White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...

Validating The Simoa Technology

Content provided by Frontage Laboratories | 01-Oct-2019 | White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Assessing Pre-Existing Antibodies in Biotheraputic Development

Content provided by Frontage Laboratories | 21-Aug-2019 | White Paper

Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...

The Truth about Physician Referrals and Clinical Trials

Content provided by BBK Worldwide | 24-Jul-2019 | White Paper

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Content provided by Baxter BioPharma Solutions | 05-Nov-2018 | White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Survey Report: State of the global pharmaceutical contract services industry 2018

Content provided by William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

How will Brexit affect the Pharmaceutical Industry?

Content provided by Source BioScience Ltd | 08-Mar-2018 | White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Survey Report: State of the Global Pharmaceutical Contract Services Industry 2017

Content provided by William Reed | 27-Jul-2017 | Application Note

In May 2017, Outsourcing-Pharma.com conducted its inaugural “state of the industry” survey of its user base of pharmaceutical industry professionals, including...

The Power to Make, A Virtual Tour

Content provided by Althea | 24-Mar-2017

You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...

Looking for a prefilled option for your sensitive compound?

Content provided by Vetter Pharma International GmbH | 12-Apr-2016 | Product Brochure

With more sophisticated therapies coming to market, manufacturers need more options for complex, sensitive molecules. Vetter-Ject® is a patented, ready-to-use...

Innovative Solutions for Biologics Utilizing Advanced Aseptic Processing

Content provided by Catalent | 03-Nov-2015 | Insight Guide

In this Insight Guide, Catalent Pharma Solutions will aim to show you three things:1. Advanced Aseptic Delivery Technology: Blow-Fill-Seal2. General Requirements...

Alkermes’ successful approach to commercial scale final dosage manufacture of drug product containing highly potent API

Content provided by Alkermes Contract Pharma Services | 17-Mar-2015 | Case Study

With 45 years’ in the service business, Alkermes Contract Pharma Services, has proven expertise in drug process design  improvements, tech transfer and...

The whole blood assay: Detection of broad spectrum of pyrogens & examples of medical device testing

Merck KGaA, Darmstadt, Germany | Recorded the 09-Apr-2015 | Webinar

Pyrogens in pharmaceuticals, medical devices, biotherapeutics and cosmetics can cause fevers in humans and are potentially life-threatening. Yet standard...

Customized drug application kits

Content provided by B. Braun Melsungen AG | 02-Oct-2014 | White Paper

To avoid medication errors, application sets become more and more important for the pharmaceutical industry. These sets help to guarantee a safe and exact...

Process Transfer Excellence – Basis for a fast and successful project

Content provided by Boehringer Ingelheim Biopharmaceuticals GmbH | 30-Sep-2014 | White Paper

This whitepaper will focus on the interaction and collaboration with externals customers when transferring processes from a customer to one of Boehringer...

MARKEN DELIVERS MEDICINE TO HELP SAVE A CHILD’S LIFE

Content provided by Marken | 26-Sep-2014 | Case Study

A child in Australia is critically ill and in immediate need of a drug available only in the United Kingdom. Marken’s team of experts uses its immediate...

7 Common Myths about QP Training Debunked : A Guide for Senior Managers

Content provided by Reading Scientific Services Limited | 11-Sep-2014 | White Paper

The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK...

Developing a Good Plan B

Content provided by World Courier | 01-Sep-2014 | Best Practice

World Courier is continuously looking out for trouble on a local and global scale.  Areas of conflict that might affect transport routes? A hurricane?...

Analysis of Biopharmaceuticals to Conform to ICHQ6B

Content provided by RSSL | 24-Jul-2014 | White Paper

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by...

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

Content provided by RSSL | 19-Jun-2014 | White Paper

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical...

Learn the risk factors of metabolic syndrome and the role central labs play in aiding its detection

Content provided by ACM Global Central Laboratory | 17-Jun-2014 | Clinical Study

Metabolic syndrome, a serious condition impacting adults and children in all genders, races and ethnicities, can lead to fatal outcomes if not detected...

Setting the Standard for Plasmid DNA Production

Content provided by Boehringer Ingelheim Biopharmaceuticals GmbH | 06-Jun-2014 | Data Sheet

Boehringer Ingelheim stands out due to global contract manufacturing excellence in plasmid DNA production. It is one of the world’s leading companies for...

High Potency Manufacturing - Key selection criteria when evaluating an outsourcing partner

Content provided by Alkermes Contract Pharma Services | 08-Apr-2014 | White Paper

Many companies are choosing to outsource the manufacture of their highly potent compounds.  A provider of contract pharma services in high potent manufacturing,...

SERIALISATION

Content provided by Recipharm AB | 17-Mar-2014 | White Paper

Recipharm already has experience in serialised production. From our UK facility in Manchester over 40 batches have been delivered from a fully validated...

Global Disposable Concept at Boehringer Ingelheim

Content provided by Boehringer Ingelheim Biopharmaceuticals GmbH | 18-Feb-2014 | White Paper

Boehringer Ingelheim is one of the world’s leading companies for contract development and manufacturing of biopharmaceuticals. We are a global service...

Controlled Release and Bioavailability Enhancement

Content provided by Information not available | 28-Oct-2013 | Case Study

Metrics provides product development that leverages proprietary pharmaceutical technologies in the areas of: •    Customized Controlled Release Drug Delivery...

Making a safe choice for the manufacture of hormones

Content provided by Recipharm AB | 14-Oct-2013 | Case Study

As consumer demand for hormones increases worldwide, and formulations for manufacturing advance from microgram to milligram levels, what should you look...

Exploring New Frontiers in Direct to Patient Home Delivery Services for Clinical Trials Materials

Marken | Recorded the 10-Sep-2013 | Webinar

Exploring New Frontiers in Direct to Patient (DTP) Home Delivery Services for Clinical Trial Materials provides an in-depth look at reasons to consider...

Analytical Method Development and Validation — A CDMO Perspective

Content provided by DPT Laboratories | 28-Nov-2012 | Insight Guide

Pharmaceutical drug product development can be an expensive and time consuming process. Many challenges are faced by pharmaceutical development companies...

Smaller pharma companies financially benefitting from CDMO partnerships

Content provided by Recipharm AB | 26-Nov-2012 | Case Study

In today’s global economy, available financing is increasingly scarce for pharmaceutical companies looking to bring new products to market. Find out how...

Vetter – Answers that work

Content provided by Vetter Pharma International GmbH | 03-Oct-2012 | Data Sheet

There are many sides to your product’s success. Build them together at Vetter.Whether your injectable is still at the starting line or in full-scale production, there...

Pharmaceutical Outsourcing - key success factors

Content provided by Alkermes Contract Pharma Services | 13-Jun-2012 | White Paper

It is now considered a sound strategic move by pharmaceutical companies, from big pharma to smaller players, to increasingly rely on outsourcing service...

Ensuring Quality & Regulatory Compliance w/ Service Providers

Content provided by DPT Laboratories | 25-Jan-2012 | Data Sheet

In recent years, the pharmaceutical industry has given greater priority and attention to quality assurance and regulatory compliance than ever before....

Crystallization – Understanding and developing the process

Content provided by Solvias AG - Chemical and analytical development | 28-Nov-2011 | White Paper

In order to achieve controlled production of a desired polymorphic form it is essential to primarily understand the product and be intimately familiar...

Application of a partner-driven approach in winning and maintaining outsourced pharmaceutical business

Content provided by Alkermes Contract Pharma Services | 17-Nov-2011 | Case Study

Alkermes' Contract Pharma Services provides solid dosage form product development, formulation solutions and manufacturing services for the pharmaceutical...

Using the Four Pillars to Support Data-Driven Feasibility Success

Download our latest Foresight articleThe challenges of clinical trial recruitment are well-known to drug developers. Yet while difficulties on the macro...

The Future of Healthcare Management

Pacific Biomarkers conducts studies primarily in Preclinical through Phase IV . Traditionally, PBI has conducted studies on the efficacy of drugs in a...

Key steps to consider when working with a cdmo to identify optimal packaging options

Content provided by DPT | 28-Mar-2011 | Data Sheet

There are many factors to take into consideration when selecting or designing a packaging component. Steps involved during the initial stage of the process...

GxP, World Courier and Clinical Trial Transport

Content provided by World Courier | 21-Mar-2011

In today’s environment of increased regulatory scrutiny, the pharmaceutical industry demands the very highest quality standards in order to meet all regulatory...

Custom Manufacturing Driven by Core Competencies at Genzyme Pharmaceuticals

Content provided by Genzyme Pharmaceuticals | 21-Sep-2010 | White Paper

With global competition in custom manufacturing dramatically shifting, companies are changing business strategies to extend geographic presence, create...

Generate Sales Leads: Free White Paper

Content provided by William Reed | 02-Aug-2010 | White Paper

White papers (or technical papers) are one of the most effective ways to generate leads for your sales team and establish your company’s reputation as...

Generate sales leads with a good white paper

Content provided by William Reed | 24-Mar-2010 | White Paper

White papers (or technical papers) are one of the most effective ways to generate leads for your sales team and improve your company’s reputation as an...

The urgent need for qualified transport providers

Content provided by World Courier | 25-Jan-2010 | White Paper

In light of sobering statistics from the MHRA, WHO and others about the quality of temperature-controlled drugs and medicinal products arriving at global...

Validation of Pioglitazone in Human Serum by Two Sample Introduction Methods: LDTD-APCI/MS/MS and LC-ESI/MS/MS

Content provided by BASi | 12-Aug-2009 | White Paper

BASi’s expanded European facility provides contract research services - preclinical research, toxicology, bioanalysis, method development and pharmaceutical...

Accelerating Early Drug Development – Reality or Wishful Thinking?

Content provided by Solvias AG - Chemical and analytical development | 12-Aug-2009 | White Paper

This article focuses on the main aspects to consider when deciding whether or not to outsource chemical and analytical development – including small-scale...